Generic Drug Makers May Soon Pay for Inspection of Overseas Plants
News | 16 August 2011
(Nelson Ching/Bloomberg via Getty Images) One of the world's largest generic drug makers is calling on its fellow manufacturers to help foot the bill for the US Food and Drug Administration to conduct inspections of overseas pharmaceutical plants. ...
Click on the link to read the full article at ABC News
(This link will open in a new window)
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
